SY-13380

N/A

Report date: 2025/07/02 11:27:54
NME

Base Information

Drug NameSY-13380
Drug Alias NameSY-13380
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin/Histone-lysine N-methyltransferase 2A MLL inhibitors
TargetsHistone-lysine N-methyltransferase 2AMenin
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShouyao Holding (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShouyao Holding (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A